BioMed Research International
Volume 2015 (2015), Article ID 393670, 8 pages
http://dx.doi.org/10.1155/2015/393670

Review Article

Pediatric Glaucoma: A Literature’s Review and Analysis of Surgical Results

Gianluca Scuderi, Daniela Iacovello, Federica Pranno, Pasquale Plateroti, and Luca Scuderi

NESMOS Department, Faculty of Medicine and Psychology, Sapienza University, Via grottarossa 1035-1039, 00139 Rome, Italy

Received 26 March 2015; Accepted 27 May 2015

Academic Editor: Siavash Rahimi

Copyright © 2015 Gianluca Scuderi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

The purpose of this paper is to review the surgical options available for the management of pediatric glaucoma, to evaluate their advantages and disadvantages together with their long-term efficacy, all with the intent to give guidelines to physicians on which elements are to be considered when taking a surgical decision. Currently there is a range of surgical procedures that are being used for the management of pediatric glaucoma. Within these, some are completely new approaches, while others are improvements of the more traditional procedures. Throughout this vast range of surgical options, angle surgery remains the first choice in mild cases and both goniotomy and trabeculotomy have good success rates. Trabeculectomy with or without mitomycin C (MMC) is preferred in refractory cases, in aphakic eyes, and in older children. GDIs have a good success rate in aphakic eyes. Nonpenetrating deep sclerectomy is still rarely used; nevertheless the results of ongoing studies are encouraging. The different clinical situations should always be weighed against the risks associated with the procedures for the individual patients. Glaucomatous progression can occur many years after its stabilization and at any time during the follow-up period; for this reason life-long assessment is necessary.

1. Introduction

Pediatric glaucoma is a condition characterized by an elevated intraocular pressure (IOP) and optic nerve damage and it can be potential cause of blindness [1].

The most common classification is the following.

(1)Primary congenital glaucoma, including isolated idiopathic developmental anomalies of the angle structures.(2)Glaucoma arises in a series of systemic diseases some associated with iridocorneal trabeculodysgenesis syndrome such as Axenfeld Rieger syndrome or Peter’s anomaly [2], the phakomatoses in particular Sturge-Weber syndrome and its variants [3–5]. It can be associated also with neurofibroamatosis [6, 7], homocystinuria, Lowe’s syndrome, mucopolysaccharidosis, juvenile xanthogranuloma [8, 9].(3)Secondary glaucoma associated with acquired ocular disease.

Depending on the timing of the diagnosis and on features and circumstances of presentation of the glaucoma, aspects that must all be very carefully evaluated, surgery represents the mainstay of treatment, while topical medication may be needed for additional IOP control following surgery or as a temporary measure.

Currently, there are different surgical options, including newer surgical procedures that are improvements of the traditional ones; these in association with the use of antimetabolites and of new viewer systems contribute greatly to the improvement of the prognosis of this disease.

The purpose of this paper is to analyze the surgical options available for the management of pediatric glaucoma and to evaluate their advantages and disadvantages together with their long-term efficacy, all with the intent to give guidelines to physicians on which elements are to be considered when taking a surgical decision.

2. Angle Surgery: Goniotomy and Trabeculotomy

2.1. Goniotomy

The initial approach for primary congenital glaucoma is still angle surgery: goniotomy in the case of a clear cornea or trabeculotomy in the case of a cloudier cornea (Tables 1 and 2). Experienced surgeons have a high rate of success with this technique. Nonetheless, the patient should fit within certain criteria such as the primary congenital glaucoma with no other ocular or systemic anomalies, first diagnosed at least one month after birth but before on year of age, and the corneal diameters need to be less than 14 mm.

Table 1: Summary of angle surgery results in patients with primary congenital glaucoma.

Years
Author
Surgical technique
Eyes
Follow-up (years)
End point
Success rate

1953
Barkan
Goniotomy
196
17 yrs
IOP <20 mmHg
80%

1982
Shaffer
Goniotomy
287
15 yrs
IOP <20 mmHg
76.7%

1979
Lunz
Trabeculotomy
86
6.5 yrs
IOP <18 mmHg
89.5%

2007
Yalvac
Trabeculotomy
24
3 yrs
IOP <18 mmHg
92% 1 yr
82% 2 yrs
74% 3 yrs

Table 2: Summary of trabeculectomy surgery in primary congenital glaucoma.

Years
Author
Surgical technique
Eyes
Follow-up
End point
Success rate
%

2004
Rodrigues
Trabeculectomy:  
30 eyes with MMC 

61 eyes without MMC
91
Patients with MMC  
70.2 ± 58.2 months 

Patients without MMC  
43.8 ± 31.3 months
IOP between 15 and 21 mmHg

2010
Madhy
Trabeculectomy: 
15 eyes MMC and amniotic membrane transplantation  

15 eyes trabeculectomy MMC
30
18 months
IOP between 15 and 21 mmHg
80 

60

Intraocular pressure (IOP), mitomycin C (MMC), and millimeters of mercury (mmHg).

MMC 0.4 mg/mL for 3 minutes.

The authors did not report values of success rate; they reported values obtained by Fisher exact test for categorical variables and survival analysis to access the success rate through time. No significant difference on the failure time of the procedure, for both success IOP values considered, was observed between the groups (P = 0.746 for IOP <21 mmHg and P = 0.216 for IOP ≤15 mmHg).

Goniotomy was described for the first time by Barkan in 1948 [10] although his pioneer was actually de Vincentis who first performed it in 1893 [11]. The main aims and steps of this procedure have remained the same throughout the years; however, some modifications have been introduced, such as the use of a surgical microscope, the introduction of new goniolens (Koeppe, Barkan, Ritch), and the use of viscoelastic material to protect the cornea and lens.

The surgical steps include entering the anterior chamber, using a goniotomy knife to perform a corneal incision so as to reach the opposite side of the chamber and then incise the trabecular meshwork for 100–110 degrees, visualized using a goniolens. One of the most recently introduced is the Ritch lens; this is a direct lens that allows a 160 degree view of the angle and obstructs only half of the cornea thus making it easier to introduce the goniotomy instrument into the eye while the goniolens is in place. In case of failure it can be repeated.

Barkan in 1953 described the result of his 17 years of work with goniotomy in congenital glaucoma; he reported an 80% success rate in 188 eyes, with postoperative IOP values less than 20 mmHg without medications [12].

In 1982 Shaffer described results in 287 operated eyes. Glaucoma was considered cured if the intraocular pressure remained below 20 mmHg without medication for at least six months and cupping of the optic nerve was either the same or improved. The success rate was 76.7%. However, when the signs or symptoms of glaucoma were present at the birth or above the age of 24 months, the success rate was close to 30%. In contrast the success rate improved to 94% in cases diagnosed between the age of 1 and 24 months after one or two goniotomies [13]. This difference can be explained by the microstructural changes that are detectable in the different age groups; indeed patients over the age of 24 months are known to have less cellularity and more collagenous tissue with respect to younger patients. In the same work he also described that after 15 years of follow-up 3 patients had an increase between 20 and 30 in IOP and therefore required medical therapy [13].

Another study discussed long-term goniotomy complications; in particular the authors described a risk of relapse of glaucoma for at least 15 years. Patients whose symptoms of congenital glaucoma presented at birth were more likely to relapse than those whose symptoms developed in the first few months of life. Furthermore, eyes that required multiple goniotomies in infancy were more likely to relapse than those controlled by a single procedure (Table 3) [14].

Table 3: Summary of trabeculectomy surgery in primary congenital glaucoma and secondary glaucoma including: aphakia, aniridia, juvenile open angle glaucoma, uveitis, and Sturge-Weber syndrome.

Years
Author
Surgical technique
Eyes
Follow-up
End point
Success rate
%

1999
Freedman
Mmc trabeculectomy postoperative 5 FU or suture lysis
21
23 months
4< IOP >16 mmHg
52.4

2000
Snir
Trabeculectomy
5 FU or MMC plus postoperative 5 FU
12
25.8 ± 12.2 months
IOP <20 mmHg
58.3

2008
Giampani
MMC trabeculectomy
114
61.2 ± 26.1 months
5< IOP <21 mmHg
55.26

Intraocular pressure (IOP), millimeters of mercury (mmHg), years (yrs), mitomycin C (MMC), and 5 fluorouracile (5-FU).

MMC 0.4 mg/mL for 3 minutes.

Complications include mild and transient hyphema, cyclodialysis, iridodialysis, peripheral anterior synechiae, and cataract formation.

The preoperative presence of angular synechiae of more than 180° of circumference is associated with a failure rate of 100%. Some authors proposed preoperative laser treatment of synechiae with YAG laser [15].

2.2. Trabeculotomy

Trabeculotomy was described for the first time in 1960 by Burian; this surgical technique provided the identification of Schlemm’s canal, its radial incision, and incannulation for 360 degrees with a nylon filament. Burian described an elevated success rate [16]; however, potential false passages and the difficulty to control the nylon filament made the modification of the surgical technique necessary.

In 1970 Harms and Dannheim created a scleral superior flap, similar to the flap created for trabeculectomy, so as to have a better identification of Schlemm’s canal. He also introduced a new instrument: Harms’ trabeculotome that acts for approximately 120° and has two parallel arms that help the surgeon by providing an external guide. If one procedure alone is not enough, it can be repeated [17].

Also Allen and Burian described trabeculotomy using a rigid probe with satisfactory results [18].

No well-designed studies to compare the efficacy of a rigid probe versus the nylon filaments have been conducted as of yet, but the small studies available in literature show a similar efficacy between the two instruments.

In 1979 Luntz reported the surgical results of standard trabeculotomy for the treatment of congenital glaucoma in 86 eyes; he described a success rate of 89.5% (IOP 18 mmHg or less under anesthesia using Schiotz tonometer). The age of the patients ranged from 2 weeks to 12 years and the mean follow-up was approximately 6.5 years [19].

Yalvac et al. reported his surgical results with standard trabeculotomy after 1, 2, and 3 years of follow-up in 24 patients the success rate was, respectively, 92%, 82%, and 74%. The end point was IOP less than 18 mmHg and more than 5 mmHg with a single intervention, stabilization of cup disc ratio, and lack of corneal enlargement [20].

A recent study by Ou and Caprioli reported a success rate ranging from 87% to 92% in case of primary congenital glaucoma presenting before one year of age [21].

In the last years a 360° trabeculotomy with an illuminated microcatheter has been described.

The use of illuminated probes allows for controlled visualization of the position of the catheter while advancing along Shlemm’s canal. Dao et al. reported a 75% success rate in achieving 360° cannulation as an initial procedure in children with primary congenital glaucoma [22].

Several studies compared the efficacy of goniotomy and trabeculotomy and concluded that both are successful techniques [23, 24]. There is a general consensus to use goniotomy for initial forms with clear cornea and trabeculotomy for mild severe forms with corneal opacity.

Complications include transient hyphema, choroidal detachments or hemorrhage, and false passage into the eye; less common complications are iridodialysis and rupture of the Descemet membrane [25, 26].

2.3. Trabeculectomy

Trabeculectomy is a filtering procedure that is generally utilized if angle surgery in primary congenital glaucoma fails to work; however, some surgeons prefer to perform it as primary choice in aphakic glaucoma [25].

Although several studies report acceptable results, the success rate is lower than that reported in adult patients and varies from 35 to 50% [26–30]. Several studies report the enhanced success (54% to 85%) of this procedure when used as the primary intervention for congenital glaucoma [31]. Trabeculectomy presents special technical difficulties in childhood because buphthalmic eyes are bigger than usual and the lumbar anatomy is frequently impaired and it can lead to iris and ciliary body incarceration and vitreous loss [30–33]. Furthermore in childhood there is an exuberant fibrotic postoperative response with scar formation which occludes the filtering site and causes long-term trabeculectomy failure. To obviate this drawback the use of antimetabolites has been introduced. Freedman et al. retrospectively reviewed 21 eyes of 17 patients (mean age 2.6 years, minimum 1 month maximum 16 years) who underwent mitomycin C (MMC) trabeculectomy, selective use of postoperative 5 fluorouracile (5-FU), and diode laser suture lyses in patients suffering from refractory primary and secondary glaucoma. The follow-up period for all cases was months. The preoperative IOP of  mmHg was reduced to the mean values of  mmHg at last follow-up, with a mean IOP decrement of  mmHg (). The use of preoperative eye drops (for all cases) was reduced from before operation to after operation ().

The cumulative success rate was 54.2%. A lower success rate was noted in patients younger than 1 year of age (30%) compared with those older than one year (73%) and in aphakic eyes (2%) compared with the phakic ones (64%) [34]. The reason is unknown. Beauchamp and Parks described a more exuberant healing response which together with a thicker Tenon’s layer and lower scleral rigidity and thickness may be considered responsible [30]. Although others have noted poor success of MMC-augmented trabeculectomy in aphakic children, the reasons for frequent failure in these patients are unknown [35]. Susanna Jr. et al. reported an overall success rate (IOP between 4 and 21 mmHg) in 67% of 79 eyes patients (mean age of 76 months and a mean follow-up of 17 months), with devastating complications in 3 eyes [36].

The use of antimetabolites led to the improvement of the prognosis, but at the same time other complications were reported: thin avascular bleb, bleb related endophthalmitis, and long-term hypotonia and bleb leak carry substantial ocular morbidity and the potential for visual loss as well as the need for additional surgery. An increased incidence of postoperative complications is reported in mitomycin trabeculectomy comparing to trabeculectomy without antimetabolites [37–39]. Sidoti et al. reported a significant incidence of endophthalmitis in childhood compared to the rates reported in adults [28].

In the early postoperative period, the most common complications faced by the glaucoma surgeons involve either elevated IOP or hypotonia. Other complications are wound leak, choroidal hemorrhage, malignant glaucoma, cystoid macular edema, encapsulated bleb iris prolapsed, and synechiae [28–40].

Major intraoperative complications in particular expulsive choroidal hemorrhage and intraoperative choroidal effusion are more frequent in eyes with glaucoma secondary to Sturge-Weber syndrome.

The reason is due to vascular anomalies and increased pressure in episcleral veins, ciliary body veins, and choroidal veins that quickly loose fluid from the intravascular to the extravascular space when eyes are opened and intraocular pressure suddenly declines. To prevent this rare but potential catastrophic event the authors have proposed prophylactic intervention such as posterior sclerotomy, prophylactic radiotherapy or laser photocoagulation of the choroidal hemangioma, or electrocautery of the anterior episcleral vascular anomaly, also the reduction of intraoperative hypotonia by a rapid closure of the scleral flap seem to be effective to reduce the risk of expulsive choroidal hemorrhage and intraoperative choroidal effusion [41].

2.4. Glaucoma Drainage Implants

Glaucoma drainage implants (GDIs) provide an alternative option for IOP reduction in complicated pediatric glaucomas that are refractory to angle or filtering surgery. GDIs employ a silicon tube placed in the anterior chamber to shunt aqueous humor to the subconjunctival space where it is connected to a plate positioned in the equator region. A fibrous capsule forms around this plate. The size and the material of the plates vary between the different devices.

The first drainage system utilized was the Molteno valves in 1970 [42]. Afterwards other valves were introduced; the most utilized actually together with Molteno implants are Bearveldt and Ahmed valves [43].

The Ahmed valve is a device with a unidirectional valve restriction flow mechanism, designed to open when IOP is higher than 8 mmHg. This design is highly effective to reduce postoperative hypotonia compared to nonvalved devices which requires a two-step procedure to prevent postsurgical hypotonia and the use of medication to control IOP until the tube opens. Success rate in the different studies varies considerably from 31.3% to 92.7%; this huge difference is due to the different populations enrolled, different devices utilized, and different follow-up lengths (Tables 4 and 5) [4–47]. For instance Al-Mobarak and Khan reported a low success rate of 31% after two years in patients younger than 2 years while Al-Mobarak and Khan reported a success rate of 86% in patients with a median age of 6 years [48]. Yang and Park reported in 38 eyes with congenital glaucoma and 41 with aphakic glaucoma success rates of 92 and 90%, respectively, at 1 year of follow-up which decreased to 42 and 55% after 10 years [49]. Several studies performed on young patients did not show significant differences in postoperative IOP values [50, 51].

Table 4: Summary of GDIs implants surgery in patients with primary congenital glaucoma.

Years
Author
Type of valve implanted
Eyes
Follow-up
End point
Success rate
%

2004
Al Torbak
Ahmed with corneal transplant
20
30.9 months
IOP between 5 and 21 mmHg without medical or surgery additional intervention
44 at 2 yrs
33 at 4 yrs

2014
Audrey
Bearveldt
45
30 months
IOP <21 mmHg
93.3 at 3–9 months 
86.7 at 12–18 months 86.7 at 24–30 months

2014
Reza Razeghinejad
Ahmed
33
32 ± 18.3 months
IOP <21 mmHg
97 1 yr
85 2 yrs
56 5 yrs

Intraocular pressure (IOP), years (yrs), and millimeters of mercury (mmHg).

Table 5: Summary of GDIs implants surgery in patients with primary congenital glaucoma and secondary glaucoma including: aniridia, peter’s anomaly, neovascular glaucoma, aphakic glaucoma following congenital cataract extraction, microphthalmia glaucoma after trauma, glaucoma following retinal detachment surgery, and juvenile glaucoma.

Years
Author
Type of valve implanted
Eyes
Follow-up
End point
Success rate
%

1997
Eid
Molteno single or double plaits, Soker, Beraveldt
18
47.3 ± 25.1 months
6< IOP <21 mmHg
44.4

2007
Autrata
Molteno or Bearveldt
76
7.1 ± 6.5 yrs
7< IOP <21 mmHg
91 at 1 yr
82 at 2 yrs
76 at 3 yrs 
71 at 4 yrs
67 at 5 yrs

2008
O’malley
Ahmed, Bearveldt, Molteno
79
5.5 yrs (mean)
IOP <21 mmHg
92–90 at 1  yrs
42–55 after 10 yrs

2009
Al Mobarak
Ahmed
42
11.1 ± 5.5 months
IOP <22 mmHg
73.8 at 1 yr
63.3 at 2 yrs

2009
Khan
Ahmed
31
11.8 ± 5.6 months
IOP <22 mmHg
90.9 at 2 yrs
58.4 at 2 yrs

Intraocular pressure (IOP), years (yrs), and millimeters of mercury (mmHg).

A meta-analysis of aqueous shunts by Minckler et al. revealed no advantages to the adjunctive use of antifibrotic agents or systemic corticosteroids [52]. The paucity of evidence that MMC improves outcomes and its potential complications have led to their more limited use [53, 54].

Freedman et al. comparison of GDIs and MMC trabeculectomy shows a major success rate of the former one in both short and long term (87% versus 36% at one year and 53% versus 19% at 6 six years) [55]. These results are confirmed in other studies. Pakravan et al. reported a success rate of 87% (IOP between 5 and 21 mmHg) in aphakic glaucoma treated with Ahmed implants versus 67% in those treated with MMC trabeculectomy 40%. He also reported an increase of complication rate in the MMC trabeculectomy group (40% versus 26.7%) [56].

The complications associated with GDIs are largely reported and seem to be more frequent in childhood compared to adulthood. The most frequent complications are shallows and flats in the anterior chamber, hypotonia, hyphema, choroidal effusion, corneal tube contact, iris abnormalities, and endophthalmitis associated with tube extrusion. Strabismus has been described after GDIs and it is due to the placement of the implant in the vicinity of the rectus muscle insertion [57–61].

In Sturge-Weber syndrome higher rate of expulsive choroidal hemorrhage, choroidal effusion, and prolonged flat anterior chamber are described. Hamush et al. reported choroidal detachment in 3 eyes of 11 patients [62]. Amini et al. reported 3 cases of choroidal detachment in 9 patients with Sturge-Weber related glaucoma who underwent Ahmed valve implantation [63]. Budenz et al. reported a serous choroidal detachment in two patients of 9 patients (20%) which underwent Baerveldt valve implant resolved spontaneously without the need to drain, the self-limiting nature of this complacence was due to prophylactic posterior sclerotomies performed, in more than one quadrant [64].

2.5. Deep Sclerectomy

Deep sclerectomy (NPDS) involves the unroofing of Schlemm’s canal under a scleral flap, with concurrent removal of juxtacanalicular trabecular tissues and creation of a trabeculodescemetic window that provides the resistance to aqueous drainage, in order to prevent hypotonia. This procedure is technically more demanding so its use is not generalized and it is even more limited in childhood. Only few studies are reported in literature [65, 66]. A prospective study conducted in Saudi Arabia by Al-Obeidan et al. regarding NPDS as first surgical choice in 120 patients with PCG reported a success rate of 82.4% [67].

NPDS is particularly suitable in complicated glaucoma such as Sturge-Weber syndrome where hypotonia and choroidal effusion can have catastrophic consequences. Audren et al. did not report any cases of choroidal effusion of NPDS in 12 eyes of nine patients (follow-up 26 months) with glaucoma related to Sturge-Weber syndrome. So it may be considered theoretically safer than trabeculectomy and GDI and could be regarded as an alternative when possible [68].

3. Conclusions

Management of congenital glaucoma is still a challenge for physicians, starting from diagnosis passing through the timing and choice of the most appropriate surgical approach and ending with the long-term follow-up. Today diagnosis is facilitated with ultrasound biomicroscopy and optical coherence tomography of the anterior segment which are imaging techniques which can show the angle and surrounding structures with great detail [69, 70]. Intraocular pressure generally is measured under anesthesia; however, most anesthetic drugs lower it. Generally ketamine is avoided since it raises the values of intraocular pressure. Various instruments can be used to measure intraocular pressure in children like the rebound tonometer, the pneumotonometer, and Perkins applanation tonometer. In particular the I-care tonometer has shown to be promising in measuring IOP in awake young children [71]. Its validity and limits are well known in adult patients [72]. New surgical techniques and improvements of the traditional ones are available to manage pediatric glaucoma, which, however, remains still a challenging and niche type of surgery, probably also due to its low worldwide incidence. The different clinical situations should always be weighed against the risks associated with the procedures for the individual patients.

It is generally accepted that angle surgery remains the first choice in mild cases and both goniotomy and trabeculotomy have good success rates.

Trabeculectomy with or without MMC is preferred in refractory cases, in aphakic eyes and in older children. GDIs have a good success rate in aphakic eyes.

NPDS is still rarely used to date for long-term follow-up are available but medium term results of on-going studies are encouraging. There is also a paucity of information on sight-threatening complications. De Silva et al. evaluate the risk of glaucomatous progression in 19 patients (mean follow up of 33 years) evaluating at each control: elevation of the disk, IOP, progression of optic disk cupping, and visual fields.

Goniotomy was the first surgical approach in 27 eyes, 2 of these eyes needed a second goniotomy. Nine eyes (30%) were treated with trabeculectomy: 2 eyes with MMC 1 eye with β-irradiation, 1 eye secondary trabeculectomy with MMC after 19 years, and 2 eyes requiring transscleral cyclodiode laser. A total of 9 eyes (30%) showed progressive PCG, with a reduction of visual acuity >0.2logMAR units and/or progression of optic disk cupping >0.2 cup/disk ratio as a consequence of elevated IOP (>21 mmHg). The authors have found that the glaucomatous progression can occur many years after its stabilization and at any time during the follow-up period.

The authors hypothesized that the increased visual impairment with long-term follow-up is partly a consequence of sight threatening PCG progression or ocular-comorbidity that can occur at any point in the follow-up period [73].

These results underscore the importance of a life-long assessment and necessity of monitoring the progression of damage. Standard achromatic perimetry is currently the gold standard for detecting visual field loss in glaucoma and to monitoring disease progression over time. Despite advances in imaging of the optic nerve and the retinal nerve fiber layer none of the available methods has been proven to be helpful in the clinical setting for longitudinal assessment of glaucoma [74, 75].

Considerable progress has been made in the in the diagnosis and management of congenital glaucoma but potentially it remains cause of blindness, for this reason innovative studies are required to improve the existing medical and surgical options and to experiment newer.

Conflict of Interests

No conflicting relationship exists for any author.

References

C. Cedrone, C. Nucci, G. Scuderi, F. Ricci, A. Cerulli, and F. Culasso, “Prevalence of blindness and low vision in an Italian population: a comparison with other European studies,” Eye, vol. 20, no. 6, pp. 661–667, 2006.

Z. Tümer and D. Bach-Holm, “Axenfeld-Rieger syndrome and spectrum of PITX2 and FOXC1 mutations,” European Journal of Human Genetics, vol. 17, no. 12, pp. 1527–1539, 2009.

E. Sujansky and S. Conradi, “Sturge-Weber syndrome: age of onset of seizures and glaucoma and the prognosis for affected children,” Journal of Child Neurology, vol. 10, no. 1, pp. 49–58, 1995.

T. J. Sullivan, M. P. Clarke, and J. D. Morin, “The ocular manifestations of the Sturge-Weber syndrome,” Journal of Pediatric Ophthalmology and Strabismus, vol. 29, no. 6, pp. 349–356, 1992.

S. M. Recupero, S. Abdolrahimzadeh, M. De Dominicis, and R. Mollo, “Sturge-Weber syndrome associated with naevus of Ota,” Eye, vol. 12, no. 2, pp. 212–213, 1998.

J. Morales, I. A. Chaudhry, and T. M. Bosley, “Glaucoma and globe enlargement associated with neurofibromatosis type 1,” Ophthalmology, vol. 116, no. 9, pp. 1725–1730, 2009.

S. M. Recupero, R. Plateroti, S. Abdolrahimzadeh et al., “Lisch nodules in neurofibromatosis type I. Relationship to age and cutaneous neurofibromas,” Anals of Ophthalmology, vol. 28, no. 3, pp. 178–183, 1996.

D. S. Walton, G. Katsavounidou, and C. U. Lowe, “Glaucoma with the oculocerebrorenal syndrome of Lowe,” Journal of Glaucoma, vol. 14, no. 3, pp. 181–185, 2005.

H. E. Cross and A. D. Jensen, “Ocular manifestations in the Marfan syndrome and homocystinuria,” American Journal of Ophthalmology, vol. 75, no. 3, pp. 405–420, 1973.

O. Barkan, “Goniotomy for the relief of congenital glaucoma,” British Journal of Ophthalmology, vol. 32, no. 9, pp. 701–728, 1948.

C. de Vincentis, “Angle incision in glaucoma,” Annals of Ophthalmology, vol. 22, pp. 540–542, 1983.

O. Barkan, “Surgery of congenital glaucoma. Review of 196 eyes operated by goniotomy,” The American Journal of Ophthalmology, vol. 36, no. 11, pp. 1523–1534, 1953.

R. N. Shaffer, “Prognosis of goniotomy in primary infantile glaucoma (Trabeculodysgenesis),” Transactions of the American Ophthalmological Society, vol. 80, pp. 321–325, 1982.

I. M. Russell-Eggitt, N. S. C. Rice, B. Jay, and R. K. H. Wyse, “Relapse following goniotomy for congenital glaucoma due to trabecular dysgenesis,” Eye, vol. 6, no. 2, pp. 197–200, 1992.

G. L. Scuderi and N. Pasquale, “Laser therapies for glaucoma: new frontiers,” Progress in Brain Research, vol. 173, pp. 225–236, 2008.

H. M. Burian, “A case of Marfan's syndrome with bilateral glaucoma. With description of a new type of operation for developmental glaucoma (trabeculotomy ab externo),” American Journal of Ophthalmology, vol. 50, no. 6, pp. 1187–1192, 1960.

H. Harms and R. Dannheim, “Epicritical consideration of 300 cases of trabeculotomy ab externo,” Transactions of the Ophthalmological Societies of the United Kingdom, vol. 89, pp. 491–499, 1970.

L. Allen and H. M. Burian, “Trabeculotomy ab externo. A new glaucoma operation: technique and results of experimental surgery,” American Journal of Ophthalmology, vol. 53, no. 1, pp. 19–26, 1962.

M. H. Luntz, “Congenital, infantile, and juvenile glaucoma,” Ophthalmology, vol. 86, no. 5, pp. 793–802, 1979.

I. S. Yalvac, B. Satana, A. Suveren, U. Eksioglu, and S. Duman, “Success of trabeculotomy in patients with congenital glaucoma operated on within 3 months of birth,” Eye, vol. 21, no. 4, pp. 459–464, 2007.

Y. Ou and J. Caprioli, “Surgical management of pediatric glaucoma,” Developments in Ophthalmology, vol. 50, pp. 157–172, 2012.

J. B. Dao, S. R. Sarkisian Jr., and S. F. Freedman, “Illuminated microcatheter-facilitated 360-degree trabeculotomy for refractory aphakic and juvenile open-angle glaucoma,” Journal of Glaucoma, vol. 23, no. 7, pp. 449–454, 2014.

D. R. Anderson, “Trabeculotomy compared to goniotomy for glaucoma in children,” Ophthalmology, vol. 90, no. 7, pp. 805–806, 1983.

G. Kiefer, O. Schwenn, and F. Grehn, “Correlation of postoperative axial length growth and intraocular pressure in congenital glaucoma—a retrospective study in trabeculotomy and goniotomy,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 239, no. 12, pp. 893–899, 2001.

A. Azuara-Blanco, R. P. Wilson, G. L. Spaeth, C. M. Schmidt, and J. J. Augsburger, “Filtration procedures supplemented with mitomycin C in the management of childhood glaucoma,” British Journal of Ophthalmology, vol. 83, no. 2, pp. 151–156, 1999.

T. Fulcher, J. Chan, B. Lanigan, R. Bowell, and M. O'Keefe, “Long-term follow up of primary trabeculectomy for infantile glaucoma,” British Journal of Ophthalmology, vol. 80, no. 6, pp. 499–502, 1996.

J. Sturmer, D. C. Broadway, and R. A. Hitchings, “Young patient trabeculectomy. Assessment of risk factors for failure,” Ophthalmology, vol. 100, no. 6, pp. 928–939, 1993.

P. A. Sidoti, S. J. Belmonte, J. M. Liebmann, and R. Ritch, “Trabeculectomy with mitomycin-C in the treatment of pediatric glaucomas,” Ophthalmology, vol. 107, no. 3, pp. 422–429, 2000.

J. Whiteside-Michel, J. M. Liebmann, and R. Ritch, “Initial 5-fluorouracil trabeculectomy in young patients,” Ophthalmology, vol. 99, no. 1, pp. 7–13, 1992.

G. R. Beauchamp and M. M. Parks, “Filtering surgery in children: barriers to success,” Ophthalmology, vol. 86, no. 1, pp. 170–180, 1979.

T. Fulcher, J. Chan, B. Lanigan, R. Bowell, and M. O'Keefe, “Long term follow up of primary trabeculectomy for infantile glaucoma,” British Journal of Ophthalmology, vol. 80, no. 6, pp. 499–502, 1996.

P. T. Khaw, “What is the best primary surgical treatment for the infantile glaucomas?” British Journal of Ophthalmology, vol. 80, no. 6, pp. 495–496, 1996.

V. Hauviller, “Gonioscopic findings in trabeculectomies in young children,” Journal of Pediatric Ophthalmology and Strabismus, vol. 26, no. 3, pp. 133–135, 1989.

S. F. Freedman, K. McCormick, and T. A. Cox, “Mitomycin C-augumented trabeculectomy with postoperative wound modulation in pediatric glaucoma,” Journal of AAPOS, vol. 3, no. 2, pp. 117–124, 1999.

K. Brady, J. Davis, A. Biglan, S. Atkinson, and D. Hiles, “Use of mitomycin C with glaucoma filtering surgery in pediatric glaucoma,” in Proceedings of the AAPOS Annual Meeting, 1995.

R. J. Susanna Jr., E. W. Oltrogge, J. C. E. Carani, and M. T. Nicolela, “Mitomycin as adjunct chemotherapy with trabeculectomy in congenital and developmental glaucomas,” Journal of Glaucoma, vol. 4, no. 3, pp. 151–152, 1995.

P. Dureau, H. Dollfus, C. Cassegrain, and J.-L. Dufier, “Long-term results of trabeculectomy for congenital glaucoma,” Journal of Pediatric Ophthalmology and Strabismus, vol. 35, no. 4, pp. 198–202, 1998.

J. Giampani Jr., A. S. Borges-Giampani, J. C. E. Carani, E. W. Oltrogge, and R. Susanna Jr., “Efficacy and safety of trabeculectomy with mitomycin C for childhood glaucoma: a study of results with long-term follow-up,” Clinics, vol. 63, no. 4, pp. 421–426, 2008.

A. M. Rodrigues, A. P. Júnior, F. T. Montezano, P. A. de Arruda Melo, and J. P. Júnior, “Comparison between results of trabeculectomy in primary congenital glaucoma with and without the use of mitomycin C,” Journal of Glaucoma, vol. 13, no. 3, pp. 228–232, 2004.

R. Susanna Jr., E. W. Oltrogge, J. C. E. Carani, and M. T. Nicolela, “Mitomycin as adjunct chemotherapy with trabeculectomy in congenital and developmental glaucomas,” Journal of Glaucoma, vol. 4, no. 3, pp. 151–157, 1995.

M. Eibschitz-Tsimhoni, P. R. Lichter, M. A. del Monte et al., “Assessing the need for posterior sclerotomy at the time of filtering surgery in patients with Sturge-Weber syndrome,” Ophthalmology, vol. 110, no. 7, pp. 1361–1363, 2003.

A. Molteno, “Children with advanced glaucoma treated dy draining implants,” South African Archives of Ophthalmology, vol. 1, pp. 55–72, 1970.

P. A. Netland and D. S. Walton, “Glaucoma drainage implants in pediatric patients,” Ophthalmic Surgery, vol. 24, no. 11, pp. 723–729, 1993.

M. R. Djodeyre, J. Peralta Calvo, and J. Abelairas Gomez, “Clinical evaluation and risk factors of time to failure of Ahmed Glaucoma Valve implant in pediatric patients,” Ophthalmology, vol. 108, no. 3, pp. 614–620, 2001.

Y. Morad, C. E. Donaldson, Y. M. Kim, M. Abdolell, and A. V. Levin, “The Ahmed drainage implant in the treatment of pediatric glaucoma,” American Journal of Ophthalmology, vol. 135, no. 6, pp. 821–829, 2003.

D. L. Budenz, S. J. Gedde, J. D. Brandt, D. Kira, W. Feuer, and E. Larson, “Baerveldt glaucoma implant in the management of refractory childhood glaucomas,” Ophthalmology, vol. 111, no. 12, pp. 2204–2210, 2004.

C. R. de Moura, S. Fraser-Bell, A. Stout, L. Labree, M. Nilfors, and R. Varma, “Experience with the baerveldt glaucoma implant in the management of pediatric glaucoma,” The American Journal of Ophthalmology, vol. 139, no. 5, pp. 847–854, 2005.

F. Al-Mobarak and A. O. Khan, “Two-year survival of Ahmed valve implantation in the first 2 years of life with and without intraoperative mitomycin-C,” Ophthalmology, vol. 116, no. 10, pp. 1862–1865, 2009.

H. K. Yang and K. H. Park, “Clinical outcomes after Ahmed valve implantation in refractory paediatric glaucoma,” Eye, vol. 23, no. 6, pp. 1427–1435, 2009.

D. Lee, D. H. Shin, C. M. Birt et al., “The effect of adjunctive mitomycin C in Molteno implant surgery,” Ophthalmology, vol. 104, no. 12, pp. 2126–2135, 1997.

V. P. Costa, A. Azuara-Blanco, P. A. Netland, M. R. Lesk, and E. S. Arcieri, “Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma Valve implantation: a prospective randomized clinical tria,” Ophthalmology, vol. 111, no. 6, pp. 1071–1076, 2004.

D. Minckler, G. Baerveldt, M. A. Ramirez et al., “Clinical results with the Trabectome, a novel surgical device for treatment of open-angle glaucoma,” Transactions of the American Ophthalmological Society, vol. 104, pp. 40–47, 2006.

N. Nassiri, N.-M. Kouros, and A. L. Coleman, “Ahmed glaucoma valve in children: a review,” Saudi Journal of Ophthalmology, vol. 25, no. 4, pp. 317–327, 2011.

A. D. Beck, S. Freedman, J. Jin, and J. Kammer, “Aqueous shunt devices compared with trabeculectomy with mitomycin-C for children in the first two years of life,” The American Journal of Ophthalmology, vol. 137, no. 6, pp. 1163–1164, 2004.

D. S. Minckler, B. A. Francis, E. A. Hodapp et al., “Aqueous shunts in glaucoma. A report by the American Academy of Ophthalmology,” Ophthalmology, vol. 115, no. 6, pp. 1089–1098, 2008.

M. Pakravan, N. Homayoon, Y. Shahin, and B. R. A. Reza, “Trabeculectomy with mitomycin C versus ahmed glaucoma implant with mitomycin C for treatment of pediatric aphakic glaucoma,” Journal of Glaucoma, vol. 16, no. 7, pp. 631–636, 2007.

M. L. Wellemeyer and F. W. Price Jr., “Molteno implants in patients with previous cyclocryotherapy,” Ophthalmic Surgery, vol. 24, no. 6, pp. 395–398, 1993.

K. Nouri-Mahdavi and J. Caprioli, “Evaluation of the hypertensive phase after insertion of the Ahmed Glaucoma Valve,” American Journal of Ophthalmology, vol. 136, no. 6, pp. 1001–1008, 2003.

M. Eibschitz-Tsimhoni, R. M. Schertzer, D. C. Musch, and S. E. Moroi, “Incidence and management of encapsulated cysts following Ahmed glaucoma valve insertion,” Journal of Glaucoma, vol. 14, no. 4, pp. 276–279, 2005.

A. D. Beck, S. Freedman, J. Jin, and J. Kammer, “Aqueous shunt devices compared with trabeculectomy with mitomycin-C for children in the first two years of life,” American Journal of Ophthalmology, vol. 137, no. 6, pp. 1163–1164, 2004.

Y. Ou, F. Yu, S. K. Law, A. L. Coleman, and J. Caprioli, “Outcomes of Ahmed glaucoma valve implantation in children with primary congenital glaucoma,” Archives of Ophthalmology, vol. 127, no. 11, pp. 1436–1441, 2009.

N. G. Hamush, A. L. Coleman, and M. R. Wilson, “Ahmed glaucoma valve implant for management of glaucoma in Sturge-Weber syndrome,” American Journal of Ophthalmology, vol. 128, no. 6, pp. 758–760, 1999.

H. Amini, M. R. Razeghinejad, and B. Esfandiarpour, “Primary single-plate Molteno tube implantation for management of glaucoma in children with Sturge-Weber syndrome,” International Ophthalmology, vol. 27, no. 6, pp. 345–350, 2007.

D. L. Budenz, D. Sakamoto, R. Eliezer, R. Varma, and D. K. Heuer, “Two-staged baerveldt glaucoma implant for childhood glaucoma associated with sturge-weber syndrome,” Ophthalmology, vol. 107, no. 11, pp. 2105–2110, 2000.

M. Feusier, S. Roy, and A. Mermoud, “Deep sclerectomy combined with trabeculectomy in pediatric glaucoma,” Ophthalmology, vol. 116, no. 1, pp. 30–38, 2009.

C. Lüke, T. S. Dietlein, P. C. Jacobi, W. Konen, and G. K. Krieglstein, “Risk profile of deep sclerectomy for treatment of refractory congenital glaucomas,” Ophthalmology, vol. 109, no. 6, pp. 1066–1071, 2002.

S. A. Al-Obeidan, E. E.-D. A. Osman, A. S. Dewedar, P. Kestelyn, and A. Mousa, “Efficacy and safety of deep sclerectomy in childhood glaucoma in Saudi Arabia,” Acta Ophthalmologica, vol. 92, no. 1, pp. 65–70, 2014.

F. Audren, O. Abitbol, P. Dureau et al., “Non-penetrating deep sclerectomy for glaucoma associated with Sturge–Weber syndrome,” Acta Ophthalmologica Scandinavica, vol. 84, no. 5, pp. 656–660, 2006.

W. Nolan, “Anterior segment imaging: ultrasound biomicroscopy and anterior segment optical coherence tomography,” Current Opinion in Ophthalmology, vol. 19, no. 2, pp. 115–121, 2008.

G. Mannino, R. Malagola, S. Abdolrahimzadeh, G. M. Villani, and S. M. Recupero, “Ultrasound biomicroscopy of the peripheral retina and the ciliary body in degenerative retinoschisis associated with pars plana cysts,” British Journal of Ophthalmology, vol. 85, no. 8, pp. 976–982, 2001.

Y. Li, S. Jia, P. Liu et al., “Application of Icare rebound tonometer in children after congenital cataract surgery,” Zhong Nan Da Xue Xue Bao Yi Xue Ban, vol. 40, no. 1, pp. 72–77, 2015.

G. L. Scuderi, N. C. Cascone, F. Regine, A. Perdicchi, A. Cerulli, and S. M. Recupero, “Validity and limits of the rebound tonometer (ICare): clinical study,” European Journal of Ophthalmology, vol. 21, no. 3, pp. 251–257, 2011.

D. J. De Silva, P. T. Khaw, and J. L. Brookes, “Long-term outcome of primary congenital glaucoma,” Journal of AAPOS, vol. 15, no. 2, pp. 148–152, 2011.

K. Nouri-Mahdavi, N. Nassiri, A. Giangiacomo, and J. Caprioli, “Detection of visual field progression in glaucoma with standard achromatic perimetry: a review and practical implications,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 249, no. 11, pp. 1593–1616, 2011.

G. L. Scuderi, M. Cesareo, A. Perdicchi, and S. M. Recupero, “Standard automated perimetry and algorithms for monitoring glaucoma progression,” Progress in Brain Research, vol. 173, pp. 77–99, 2008.